An innovation for delivering objective, real-time assessment of tissue changes beneath the skin
Diagnosing lymphedema remains challenging due to overlapping symptoms with other conditions, lack of early detection methods, and limited access to specialized diagnostics.
TissueIQ is an innovative multi-modal analyzer designed to provide objective, real-time assessment of tissue changes beneath the skin, offering a modern approach to detecting early and progressive lymphedema-related changes, often before visible swelling occurs.
A FDA-cleared wearable compression treatment indicated for the treatment of lymphedema, phlebolymphedema, venous insufficiency, lipedema, related conditions to chronic edema and supports mobility during treatment1.
Multiple randomized controlled studies including NILE (2022) and TEAYS (2024) showed that Dayspring provides superior outcomes in edema reduction, quality of life, and adherence compared to standard of care2,3.
Lymphedema is a progressive, chronic disease for which there’s no cure. It is caused by impaired lymphatic drainage, leading to interstitial fluid accumulation, inflammation, and fibrosis.
Learn more about our commitment to bring solutions that address unmet and undermet needs across the venous and lymphatic continuum.
.avif){kind=logo}
